Alys Pharmaceuticals is a startup based in the United States, 1 tracked investor.
Alys Pharmaceuticals is a startup based in the United States. Brouky records 1 investor associated with the company.
Alys Pharmaceuticals is a biotechnology company focused on immuno-dermatology; launched in February 2024, it consolidated assets from six companies to build an R&D-centric, multi-platform pipeline of dermatology therapeutics. The company is developing multiple programs and modalities to address unmet needs in dermatology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.